Employment Verification for Cytokinetics.

About Cytokinetics

Cytokinetics is a biopharmaceutical company founded in 1997, headquartered in South San Francisco, California. The company is focused on the discovery and development of novel muscle activators for the potential treatment of diseases and conditions associated with muscle weakness and wasting. Cytokinetics’ research and development efforts have focused on developing small molecule drugs that target both skeletal and cardiac muscle function. The company’s lead drug candidate is omecamtiv mecarbil, a cardiac myosin activator that is being developed in collaboration with Amgen for the potential treatment of heart failure. Cytokinetics has also developed a drug candidate, reldesemtiv, that is being investigated for the potential treatment of amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). Reldesemtiv is designed to improve muscle function and delay disease progression in patients with these conditions. In addition to its drug development efforts, Cytokinetics has established partnerships and collaborations with pharmaceutical companies and academic institutions to further explore the potential of its muscle activator technology. Overall, Cytokinetics is dedicated to advancing the treatment of diseases and conditions associated with muscle weakness and wasting through its innovative research and drug development efforts.

The information on this page is not an endorsement of Truv’s services by Cytokinetics and is meant to be purely informational.

Verify Cytokinetics Employees

Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee, learn more.